Dental Care Clinics in Winter Park, CO Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Winter Park Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 21 King's Crossing #107, Winter Park, CO 80482 Phone: 970-726-5556 |
Keysdentalco., Pllc Wp Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 21 Kings Crossing, Suite 206, Winter Park, CO 80482 Phone: 970-726-8290 |
Ricks Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 21 Kings Crossing Road Suite #206, Winter Park, CO 80482 Phone: 716-472-5745 |
Corona Pass Dental Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 21 Kings Crossing Rd, Siute 206, Winter Park, CO 80482 Phone: 970-726-8290 Fax: 970-726-8051 |
News Archive
Discovery of one important function of junk DNA
Scientists have only recently begun to speculate that what's referred to as junk DNA , the 96 percent of the human genome that doesn't encode for proteins and previously seemed to have no useful purpose , is present in the genome for an important reason.
Researchers identify biomarkers of TB that may help in new treatments
Researchers at the University of Southampton have identified new markers of tuberculosis (TB) that may help in the development of new diagnostic tests and treatments.
Initial HSCT results from phase III trial on systemic sclerosis
Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem cell transplantation (HSCT) results in better long term survival than conventional treatment for patients with poor prognosis early diffuse cutaneous systemic sclerosis.
Scientists identify protein complex essential for jumpstarting immune response during infection
St. Jude Children's Research Hospital scientists have identified a protein complex that is essential for jumpstarting the immune response during the critical first 24 hours of an infection. The research appears in the current issue of the scientific journal Immunity.
Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
› Verified 3 days ago